{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:37:51Z","timestamp":1793903871201,"version":"4.8.0"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHS Scotland","award":["N\/A - funding number not provided by funder"],"award-info":[{"award-number":["N\/A - funding number not provided by funder"]}]},{"DOI":"10.13039\/501100000848","name":"University Of Edinburgh","doi-asserted-by":"publisher","award":["N\/A - funding number not provided by funder"],"award-info":[{"award-number":["N\/A - funding number not provided by funder"]}],"id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014667","name":"British Neuropathological Society","doi-asserted-by":"publisher","award":["N\/A - funding number not provided by funder"],"award-info":[{"award-number":["N\/A - funding number not provided by funder"]}],"id":[{"id":"10.13039\/100014667","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arthur Fonville Award for Stroke Research","award":["N\/A - funding number not provided by funder"],"award-info":[{"award-number":["N\/A - funding number not provided by funder"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0900428"],"award-info":[{"award-number":["G0900428"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002605"],"award-info":[{"award-number":["G1002605"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000364","name":"Stroke Association","doi-asserted-by":"publisher","award":["TSA PPA 2017-01"],"award-info":[{"award-number":["TSA PPA 2017-01"]}],"id":[{"id":"10.13039\/501100000364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"British Division of the International Academy of Pathology","award":["N\/A - funding number not provided by funder"],"award-info":[{"award-number":["N\/A - funding number not provided by funder"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["214145\/Z\/18\/Z"],"award-info":[{"award-number":["214145\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2022,1,17]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Pharmacological activation of the antioxidative transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) improves outcomes in experimental models of intracerebral haemorrhage (ICH). However, the Nrf2 pathway has not been previously studied in humans after ICH. Our study aims to address this gap.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We selected cases with fatal ICH from a prospective community-based inception cohort study and age-matched and sex-matched controls who died suddenly of non-neurological disease. We used immunohistochemistry to quantify Nrf2 (% total area stained overall and % of nuclei stained) and CD68 expression in controls and perihaematomal, ipsilateral and contralateral brain tissue from cases. We measured downstream haem oxygenase-1 (HMOX1) and NAD(P)H dehydrogenase quinone 1 [NQO1] expression using RNA in situ hybridisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>26 ICH cases (median age: 82 (IQR 76\u201386); 13 (50%) male) and eight controls (median age: 79 (IQR 77\u201380); 3 (37.5%) male) were included. We found no significant differences in overall % of Nrf2 staining between ICH cases and controls. However, the mean % of nuclei staining for Nrf2 seemed higher in perihaematomal compared with contralateral regions, although this was only statistically significant &gt;60\u2009days after ICH (25% (95% CI 17% to 33%) vs 14% (95% CI 11% to 17%), p=0.029). The percentage of perihaematomal tissue staining for CD68 was higher &gt;60\u2009days after ICH (6.75%, 95%\u2009CI 2.78% to 10.73%) compared with contralateral tissue (1.45%, 95%\u2009CI 0.93% to 1.96%, p=0.027) and controls (1.08%, 95%\u2009CI 0.20% to 1.97%, p=0.0008). RNA in situ hybridisation suggested increased abundance of HMOX1 and NQO1 transcripts in perihaematomal versus distant ipsilateral brain tissue obtained &lt;7\u2009days from onset of ICH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We found evidence of Nrf2 activation in human brain tissue after ICH. Pharmacological augmentation of Nrf2 activation after ICH might be a promising therapeutic approach.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2021-000238","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T02:55:34Z","timestamp":1645325734000},"page":"e000238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Nrf2 activation in the human brain after stroke due to supratentorial intracerebral haemorrhage: a case\u2013control study"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-618X","authenticated-orcid":false,"given":"Edward","family":"Christopher","sequence":"first","affiliation":[{"name":"The University of Edinburgh College of Medicine and Veterinary Medicine, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J M","family":"Loan","sequence":"additional","affiliation":[{"name":"Division of Clinical Neurosciences, NHS Lothian, Edinburgh, UK"},{"name":"Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neshika","family":"Samarasekera","sequence":"additional","affiliation":[{"name":"Division of Clinical Neurosciences, NHS Lothian, Edinburgh, UK"},{"name":"Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"McDade","sequence":"additional","affiliation":[{"name":"Academic Neuropathology, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Rose","sequence":"additional","affiliation":[{"name":"Academic Neuropathology, The University of Edinburgh, Edinburgh, UK"},{"name":"UK Dementia Research Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Barrington","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK"},{"name":"UK Dementia Research Institute, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Smith","sequence":"additional","affiliation":[{"name":"Academic Neuropathology, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[{"name":"Division of Clinical Neurosciences, NHS Lothian, Edinburgh, UK"},{"name":"Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,19]]},"reference":[{"key":"2025072811433867000_4.1.e000238.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70025-0"},{"key":"2025072811433867000_4.1.e000238.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306476"},{"key":"2025072811433867000_4.1.e000238.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31878-6"},{"key":"2025072811433867000_4.1.e000238.4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gheart.2014.01.003","article-title":"The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study","volume":"9","author":"Krishnamurthi","year":"2014","journal-title":"Glob Heart"},{"key":"2025072811433867000_4.1.e000238.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70104-7"},{"key":"2025072811433867000_4.1.e000238.6","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2011.210294"},{"key":"2025072811433867000_4.1.e000238.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061933","article-title":"Neuronal activity and its role in controlling antioxidant genes","volume":"21","author":"Qiu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025072811433867000_4.1.e000238.8","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0463-1"},{"key":"2025072811433867000_4.1.e000238.9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300931200"},{"key":"2025072811433867000_4.1.e000238.10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M709040200"},{"key":"2025072811433867000_4.1.e000238.11","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12974"},{"key":"2025072811433867000_4.1.e000238.12","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17713105"},{"key":"2025072811433867000_4.1.e000238.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2007.04.020"},{"key":"2025072811433867000_4.1.e000238.14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.486506"},{"key":"2025072811433867000_4.1.e000238.15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009398"},{"key":"2025072811433867000_4.1.e000238.16","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2021-327098","article-title":"Secondary injury and inflammation after intracerebral haemorrhage: a systematic review and meta-analysis of molecular markers in patient brain tissue","volume":"93","author":"Loan","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025072811433867000_4.1.e000238.17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1860-14.2014"},{"key":"2025072811433867000_4.1.e000238.18","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.116"},{"key":"2025072811433867000_4.1.e000238.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135043","article-title":"Consent for brain tissue donation after intracerebral haemorrhage: a community-based study","volume":"10","author":"Samarasekera","year":"2015","journal-title":"PLoS One"},{"key":"2025072811433867000_4.1.e000238.20","doi-asserted-by":"publisher","DOI":"10.1002\/path.2247"},{"key":"2025072811433867000_4.1.e000238.21","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6030065","article-title":"Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration?","volume":"6","author":"Liddell","year":"2017","journal-title":"Antioxidants"},{"key":"2025072811433867000_4.1.e000238.22","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14379"},{"key":"2025072811433867000_4.1.e000238.23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2018.05.002","article-title":"Antioxidant response elements: discovery, classes, regulation and potential applications","volume":"17","author":"Raghunath","year":"2018","journal-title":"Redox Biol"},{"key":"2025072811433867000_4.1.e000238.24","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.007953"},{"key":"2025072811433867000_4.1.e000238.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70283-0"},{"key":"2025072811433867000_4.1.e000238.26","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199011000-00002"},{"key":"2025072811433867000_4.1.e000238.27","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000170701.41507.e1"},{"key":"2025072811433867000_4.1.e000238.28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ars.2017.7003","article-title":"A dual AMPK\/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization","volume":"28","author":"Wang","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"2025072811433867000_4.1.e000238.29","unstructured":"NICE . DIMETHYL FUMARATE | BNF: British National Formulary - NICE. Available: https:\/\/bnf.nice.org.uk\/drug\/dimethyl-fumarate.html [Accessed 12 Aug 2021]."},{"key":"2025072811433867000_4.1.e000238.30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","article-title":"The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study","volume":"17","author":"Rodrigues","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025072811433867000_4.1.e000238.31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00084","article-title":"Hypoxia-Induced oxidative stress modulation with physical activity","volume":"8","author":"Debevec","year":"2017","journal-title":"Front Physiol"},{"key":"2025072811433867000_4.1.e000238.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1514974112"},{"key":"2025072811433867000_4.1.e000238.33","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.1.221-229.2006"},{"key":"2025072811433867000_4.1.e000238.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-006-9033-y"},{"key":"2025072811433867000_4.1.e000238.35","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4222"},{"key":"2025072811433867000_4.1.e000238.36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.freeradbiomed.2019.01.016","article-title":"Redox regulation by Nrf2 in aging and disease","volume":"134","author":"Schmidlin","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"2025072811433867000_4.1.e000238.37","doi-asserted-by":"publisher","DOI":"10.1097\/nen.0b013e31802d6da9"},{"key":"2025072811433867000_4.1.e000238.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.11.004"},{"key":"2025072811433867000_4.1.e000238.39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0973-029X.141346","article-title":"Artefacts in histopathology","volume":"18","author":"Chatterjee","year":"2014","journal-title":"J Oral Maxillofac Pathol"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2021-000238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:43:52Z","timestamp":1753728232000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2021-000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,19]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bmjno-2021-000238"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2021-000238","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}